“DPP- 4 inhibitor alleviates gut-brain axis Parkinson’s disease pathology” - can dipeptidyl peptidase 4 inhibitors be repurposed as disease-modifying drugs for body-first Parkinson’s disease patients?

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Khairnar A, Rektorova I, Outeiro TF

Publication type: Note

Publication status: Published

Journal: Gut

Year: 2025

Pages: epub ahead of print

Online publication date: 13/12/2025

Acceptance date: 28/11/2025

ISSN (print): 0017-5749

ISSN (electronic): 1468-3288

Publisher: BMJ Publishing Group

URL: https://doi.org/10.1136/gutjnl-2025-336951

DOI: 10.1136/gutjnl-2025-336951

PubMed id: 41390176

ePrints